Your Article Summary
See Latest ArticlesCardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder
The Journal of Pediatrics, 07/01/09
Hammerness P et al. - Treatment with relatively high doses of OROS MPH was associated with small but statistically significant mean increases in BP and HR, primarily during the first 6 weeks of treatment, without clinically meaningful changes in ECG. These observations are consistent with previous reports using lower doses.
Related Articles
Parenting Style as a Predictor of Adolescent Weight and Weight-Related Behaviors
Journal of Adolescent Health, 10/20/09
Relevance Score: 95%
The role of parent–adolescent attachment in the glycemic control of adolescents with type 1 diabetes: A pilot study
Families, Systems & Health, 10/12/09
Relevance Score: 94%
Adolescent beverage habits and changes in weight over time: findings from Project EAT
American Journal of Clinical Nutrition, 11/02/09
Relevance Score: 92%
Discrepant Trends in Mental Health Complaints Among Younger and Older Adolescents in Sweden
Journal of Adolescent Health, 10/07/09
Relevance Score: 92%
Parenting Characteristics in the Home Environment and Adolescent Overweight: A Latent Class Analysis
Obesity, 10/14/09
Relevance Score: 91%
Today in Child/Adolescent Psych...keeping you current
Receive free subspecialty "5-minute updates" via email
Barriers to Dental Care for Children in Virginia With Autism Spectrum Disorders
Journal of Dentistry for Children, 12/04/09
Glucose enhancement of memory is modulated by trait anxiety in healthy adolescent males
Journal of Psychopharmacology, 12/03/09
Autistic disorder symptoms in Rett syndrome
Autism, 12/02/09